Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.6.6 is now shown on the page, replacing the previous v3.6.5. The update appears to be a technical version change rather than a substantive modification to the study information.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, replacing the previous version identifier. This signals an internal update to the site’s template or CMS rather than changes to visible content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing v3.6.3. This indicates a newer page revision and likely minor updates to the record without changing the study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s revision metadata includes a new revision entry (v3.6.2) with dates 2026-06-22 and 2028-06-30, and older revision markers (v3.6.0) along with several prior date entries are removed or updated. This reflects version-tracking adjustments rather than changes to the study details or disclosures.SummaryDifference0.4%

- Check93 days agoChange DetectedRecruitment status changed to No longer looking for participants, and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.